Please use this identifier to cite or link to this item:
http://hdl.handle.net/11054/21| Title: | Sepsis management and anti-endotoxin therapy after nebacumab: a reappraisal. |
| Authors: | Hurley, James C. |
| Issue Date: | 1994 |
| Publisher: | ADIS Press |
| Place of publication: | Auckland, New Zealand |
| Publication Title: | Drugs |
| Volume: | 47 |
| Issue: | 6 |
| Start Page: | 855 |
| End Page: | 861 |
| URI: | http://hdl.handle.net/11054/21 |
| ISSN: | 0012-6667 |
| Internal ID Number: | 00008 |
| Health Subject: | ANIMALS ANTIBODIES - MONOCLONAL ADVERSE EFFECTS ANTIBODIES - MONOCLONAL - THERAPEUTIC USE CLINICAL TRIALS AS TOPIC DEXAMETHASONE THERAPEUTIC USE ENDOTOXINS IMMUNOLOGY GRAM NEGATIVE BACTERIAL INFECTIONS DRUG THERAPY HUMANS METHYLPREDNISOLONE - THERAPEUTIC USE NEBACUMAB DEXAMETHASONE METHYLPREDNISOLONE |
| Type: | Journal Article Article |
| Appears in Collections: | Research Output |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.